{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:38:42Z","timestamp":1778024322153,"version":"3.51.4"},"reference-count":106,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Positron emission tomography (PET) allows for minimally invasive in vivo localization of amyloid and tau deposition, and visualization of glucose metabolism using amyloid PET, tau PET, and FDG PET. Clinically, these scans are used to determine A, T, and N (amyloid-\u03b2 plaques, tau tangles, and neurodegeneration) status in Alzheimer\u2019s disease. In light of the recent anti-amyloid therapies, determination of the A, and the associated T and N status is increasingly important. This review explores the potential of a single PET scan to define multiple biomarkers. A literature search using the PubMed database and an additional citation search using Google Scholar identified 76 relevant publications up to 30 July 2025. Original work reporting amyloid, tau or FDG PET to determine two or more ATN-related biomarkers were included. Non-English, animal, and non-dementia related studies were excluded. For each study, quantitative outcomes such as correlations and ROC AUC scores were extracted and compared. Early phase amyloid and tau PET (n = 58) were consistently found to be good indicators of N status with a median (IQR) correlation of 0.82 (0.76\u20130.86). Limited research (n = 7) was performed for amyloid or tau PET to infer both A and T status, with tau-based studies having slightly higher ROC AUC scores (0.88\u20130.99) than amyloid-based studies (0.84\u20130.9). Initial results are promising (median ROC AUC scores of 0.88 (0.81\u20130.96)) but need to be validated. FDG PET was found to be less accurate for A or T status (n = 12) prediction (median ROC AUC scores of 0.83 (0.80\u20130.87)). Among the modalities, tau PET seems to be the most promising candidate for a single tracer approach to predict all three biomarkers.<\/jats:p>","DOI":"10.3390\/brainsci15121271","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:25:16Z","timestamp":1764239116000},"page":"1271","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correlation and Interchangeability of Amyloid, Tau, and Glucose Metabolism PET in Mild Cognitive Impairment and Alzheimer: A Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2702-4293","authenticated-orcid":false,"given":"Emile","family":"Balot","sequence":"first","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Ghent University Hospital, 9000 Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefaan","family":"Vandenberghe","sequence":"additional","affiliation":[{"name":"Medical Image and Signal Processing, Faculty of Engineering, Ghent University, 9000 Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Van Langenhove","sequence":"additional","affiliation":[{"name":"Cognitive Center, Department of Neurology, Ghent University Hospital, 9000 Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"De Meulenaere","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Ghent University Hospital, 9000 Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"D\u2019Asseler","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Ghent University Hospital, 9000 Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6646-106X","authenticated-orcid":false,"given":"Donatienne","family":"Van Weehaeghe","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Ghent University Hospital, 9000 Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s Disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"ref_2","unstructured":"Alzheimer Europe (2019). Dementia in Europe Yearbook 2019: Estimating the Prevalence of Dementia in Europe, Alzheimer Europe."},{"key":"ref_3","unstructured":"Alzheimer\u2019s Disease International (2018). World Alzheimer Report 2018\u2014The State of the Art of Dementia Research: New Frontiers, Alzheimer\u2019s Disease International."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised Criteria for Diagnosis and Staging of Alzheimer\u2019s Disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An Unbiased Descriptive Classification Scheme for Alzheimer Disease Biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a Biological Definition of Alzheimer\u2019s Disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_7","unstructured":"European Medicines Agency (EMA) (2025, July 17). Leqembi. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/leqembi."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer\u2019s Disease","volume":"388","author":"Swanson","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_9","unstructured":"European Medicines Agency (EMA) (2025, October 06). Kisunla. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kisunla."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking Pathophysiological Processes in Alzheimer\u2019s Disease: An Updated Hypothetical Model of Dynamic Biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The Amyloid-\u03b2 Pathway in Alzheimer\u2019s Disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/nimg.1995.1017","article-title":"Review: Does Measurement of Regional Cerebral Blood Flow Reflect Synaptic Activity?\u2014Implications for PET and FMRI","volume":"2","author":"Jueptner","year":"1995","journal-title":"Neuroimage"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/cercor\/bhn087","article-title":"Regional Differences in the Coupling between Resting Cerebral Blood Flow and Metabolism May Indicate Action Preparedness as a Default State","volume":"19","author":"Gur","year":"2009","journal-title":"Cereb. Cortex"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13550-021-00798-3","article-title":"Deep Learning-Based Amyloid PET Positivity Classification Model in the Alzheimer\u2019s Disease Continuum by Using 2-[18F]FDG PET","volume":"11","author":"Kim","year":"2021","journal-title":"EJNMMI Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e70238","DOI":"10.1002\/hbm.70238","article-title":"Prediction Model and Nomogram for Amyloid Positivity Using Clinical and MRI Features in Individuals with Subjective Cognitive Decline","volume":"46","author":"Li","year":"2025","journal-title":"Hum. Brain Mapp."},{"key":"ref_17","unstructured":"Lyu, Q., Kim, J.Y., Kim, J., and Whitlow, C.T. (2024). Synthesizing Beta-Amyloid PET Images from T1-Weighted Structural MRI: A Preliminary Study. arXiv."},{"key":"ref_18","unstructured":"Moon, J., Kim, S., Chung, H., and Jang, I. (2025). Cyclic 2.5D Perceptual Loss for Cross-Modal 3D Medical Image Synthesis: T1w MRI to Tau PET. arXiv."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"ref_21","first-page":"146","article-title":"Correlation between Brain Glucose Metabolism (18F-FDG) and Cerebral Blood Flow with Amyloid Tracers (18F-Florbetapir) in Clinical Routine: Preliminary Evidences","volume":"41","author":"Albano","year":"2022","journal-title":"Rev. Espa\u00f1ola Med. Nucl. Imagen Mol. (Engl. Ed.)"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00259-018-4238-2","article-title":"Dual-Phase [18F]Florbetapir in Frontotemporal Dementia","volume":"46","author":"Asghar","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_23","first-page":"e12601","article-title":"Early-Phase Amyloid PET Reproduces Metabolic Signatures of Cognitive Decline in Parkinson\u2019s Disease","volume":"16","author":"Aye","year":"2024","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1007\/s00259-020-04788-w","article-title":"Early-Phase [18F]PI-2620 Tau-PET Imaging as a Surrogate Marker of Neuronal Injury","volume":"47","author":"Beyer","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/0271678X19830537","article-title":"Longitudinal Evaluation of Surrogates of Regional Cerebral Blood Flow Computed from Dynamic Amyloid PET Imaging","volume":"40","author":"Bilgel","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2967\/jnumed.122.264256","article-title":"Early-Phase 18F-Florbetapir and 18F-Flutemetamol Images as Proxies of Brain Metabolism in a Memory Clinic Setting","volume":"64","author":"Boccalini","year":"2023","journal-title":"J. Nucl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1007\/s00259-024-07063-4","article-title":"Early-Phase 18F-Flortaucipir Tau-PET as a Proxy of Brain Metabolism in Alzheimer\u2019s Disease: A Comparison with 18F-FDG-PET and Early-Phase Amyloid-PET","volume":"52","author":"Boccalini","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3233\/JAD-181188","article-title":"Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer\u2019s Disease","volume":"69","author":"Bunai","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_29","first-page":"495","article-title":"Evaluation of 10-Minute Post-Injection11C-PiB PET and Its Correlation with 18F-FDG PET in Older Adults Who Are Cognitively Healthy, Mildly Impaired, or with Probable Alzheimer\u2019s Disease","volume":"44","author":"Coutinho","year":"2022","journal-title":"Braz. J. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2967\/jnumed.114.152405","article-title":"Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET","volume":"56","author":"Chen","year":"2015","journal-title":"J. Nucl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Choi, H.J., Seo, M., Kim, A., and Park, S.H. (2023). Generation of Conventional 18F-FDG PET Images from 18F-Florbetaben PET Images Using Generative Adversarial Network: A Preliminary Study Using ADNI Dataset. Medicina, 59.","DOI":"10.3390\/medicina59071281"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nicl.2016.10.005","article-title":"Evaluation of Early-Phase [18F]-Florbetaben PET Acquisition in Clinical Routine Cases","volume":"14","author":"Daerr","year":"2017","journal-title":"Neuroimage Clin."},{"key":"ref_33","unstructured":"Dghoughi, W., Seiffert, A.P., G\u00f3mez-Grande, A., Villarejo-Galende, A., Bueno, H., G\u00f3mez, E.J., and S\u00e1nchez-Gonz\u00e1lez, P. (2019, January 27\u201329). Quantitative analysis of early-phase 18F-flutemetamol PET brain images. Proceedings of the Actas Del XXXVII Congreso Anual de La Sociedad Espa\u00f1ola de Ingenier\u00eda Biom\u00e9dica, Santander, Spain."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2967\/jnumed.123.266273","article-title":"Early-Frame [18F]Florbetaben PET\/MRI for Cerebral Blood Flow Quantification in Patients with Cognitive Impairment: Comparison to an [15O]Water Gold Standard","volume":"65","author":"Fettahoglu","year":"2024","journal-title":"J. Nucl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-180522","article-title":"Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer\u2019s Disease","volume":"66","author":"Florek","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bbadis.2011.11.006","article-title":"The Use of PIB-PET as a Dual Pathological and Functional Biomarker in AD","volume":"1822","author":"Forsberg","year":"2012","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Basis Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2967\/jnumed.124.268701","article-title":"[18F]MK-6240 Radioligand Delivery Indices as Surrogates of Cerebral Perfusion: Bias and Correlation Against [15O]Water","volume":"66","author":"Fu","year":"2025","journal-title":"J. Nucl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1007\/s00330-014-3311-x","article-title":"Comparison of Dual-Biomarker PIB-PET and Dual-Tracer PET in AD Diagnosis","volume":"24","author":"Fu","year":"2014","journal-title":"Eur. Radiol."},{"key":"ref_39","first-page":"211","article-title":"Static First-Minute-Frame (FMF) PET Imaging after 18F-Labeled Amyloid Tracer Injection Is Correlated to [18F]FDG PET in Patients with Primary Progressive Aphasia","volume":"42","author":"Seiffert","year":"2023","journal-title":"Rev. Espa\u00f1ola Med. Nucl. Imagen Mol. (Engl. Ed.)"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2967\/jnumed.122.265072","article-title":"Measurement of Cerebral Perfusion Indices from the Early Phase of [18F]MK6240 Dynamic Tau PET Imaging","volume":"64","author":"Guehl","year":"2023","journal-title":"J. Nucl. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00259-017-3840-z","article-title":"Multimodal Correlation of Dynamic [18F]-AV-1451 Perfusion PET and Neuronal Hypometabolism in [18F]-FDG PET","volume":"44","author":"Hammes","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00259-011-2051-2","article-title":"Correlation of Early-Phase 18F-Florbetapir (AV-45\/Amyvid) PET Images to FDG Images: Preliminary Studies","volume":"39","author":"Hsiao","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s13139-019-00612-y","article-title":"Correlation of Early-Phase F-18 Florapronal PET with F-18 FDG PET in Alzheimer\u2019s Disease and Normal Brain","volume":"53","author":"Jeong","year":"2019","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"ref_44","first-page":"669","article-title":"Utility of Perfusion PET Measures to Assess Neuronal Injury in Alzheimer\u2019s Disease","volume":"10","author":"Su","year":"2018","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Kwon, S.J., Ha, S., Yoo, S.W., Shin, N.Y., O, J.H., Yoo, I.R., and Kim, J.S. (2021). Comparison of Early F-18 Florbetaben PET\/CT to Tc-99m ECD SPECT Using Voxel, Regional, and Network Analysis. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-95808-8"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jalz.2017.11.008","article-title":"Longitudinal Uncoupling of Cerebral Perfusion, Glucose Metabolism, and Tau Deposition in Alzheimer\u2019s Disease","volume":"14","author":"Leuzy","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s00259-016-3359-8","article-title":"Imaging Characteristic of Dual-Phase 18F-Florbetapir (AV-45\/Amyvid) PET for the Concomitant Detection of Perfusion Deficits and Beta-Amyloid Deposition in Alzheimer\u2019s Disease and Mild Cognitive Impairment","volume":"43","author":"Lin","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/13872877251340380","article-title":"Evaluation of Early-Phase 18 F-Florbetaben PET as a Surrogate Biomarker of Neurodegeneration: In-Depth Comparison with 18 F-FDG PET at Group and Single Patient Level","volume":"106","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e12325","DOI":"10.1002\/trc2.12325","article-title":"Measurement of Neurodegeneration Using a Multivariate Early Frame Amyloid PET Classifier","volume":"8","author":"Matthews","year":"2022","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2967\/jnumed.110.083683","article-title":"Dual-Biomarker Imaging of Regional Cerebral Amyloid Load and Neuronal Activity in Dementia with PET and 11C-Labeled Pittsburgh Compound B","volume":"52","author":"Meyer","year":"2011","journal-title":"J. Nucl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41824-021-00123-0","article-title":"Regional Uptakes from Early-Frame Amyloid PET and 18F-FDG PET Scans Are Comparable Independent of Disease State","volume":"6","author":"Myoraku","year":"2022","journal-title":"Eur. J. Hybrid Imaging"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JAD-180274","article-title":"Can 11 C-PiB-PET Relative Delivery R 1 or 11 C-PiB-PET Perfusion Replace 18 F-FDG-PET in the Assessment of Brain Neurodegeneration?","volume":"65","author":"Oliveira","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jalz.2019.05.010","article-title":"18F-FDG PET, the Early Phases and the Delivery Rate of 18F-AV45 PET as Proxies of Cerebral Blood Flow in Alzheimer\u2019s Disease: Validation against 15O-H2O PET","volume":"15","author":"Ottoy","year":"2019","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Peretti, D.E., Garc\u00eda, D.V., Reesink, F.E., Van der Goot, T., De Deyn, P.P., De Jong, B.M., Dierckx, R.A.J.O., and Boellaard, R. (2019). Relative Cerebral Flow from Dynamic PIB Scans as an Alternative for FDG Scans in Alzheimer\u2019s Disease PET Studies. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0211000"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13550-019-0528-3","article-title":"Diagnostic Performance of Regional Cerebral Blood Flow Images Derived from Dynamic PIB Scans in Alzheimer\u2019s Disease","volume":"9","author":"Peretti","year":"2019","journal-title":"EJNMMI Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"102625","DOI":"10.1016\/j.nicl.2021.102625","article-title":"Feasibility of Pharmacokinetic Parametric PET Images in Scaled Subprofile Modelling Using Principal Component Analysis","volume":"30","author":"Peretti","year":"2021","journal-title":"Neuroimage Clin."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13550-022-00909-8","article-title":"Alzheimer\u2019s Disease Pattern Derived from Relative Cerebral Flow as an Alternative for the Metabolic Pattern Using SSM\/PCA","volume":"12","author":"Peretti","year":"2022","journal-title":"EJNMMI Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jon.12582","article-title":"Early Phase PIB-PET as a Surrogate for Global and Regional Cerebral Blood Flow Measures","volume":"29","author":"Ponto","year":"2019","journal-title":"J. Neuroimaging"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00109-025-02545-w","article-title":"Agreement between Early-Phase Amyloid-PET and Pulsed Arterial Spin Labeling in a Memory Clinic Cohort","volume":"103","author":"Ribaldi","year":"2025","journal-title":"J. Mol. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2967\/jnumed.115.168732","article-title":"Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease","volume":"57","author":"Carter","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1177\/0271678X16645593","article-title":"Comparability of [18F]THK5317 and [11C]PIB Blood Flow Proxy Images with [18F]FDG Positron Emission Tomography in Alzheimer\u2019s Disease","volume":"37","author":"Leuzy","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2967\/jnumed.110.082057","article-title":"Early 11C-PIB Frames and 18F-FDG PET Measures Are Comparable: A Study Validated in a Cohort of AD and FTLD Patients","volume":"52","author":"Rostomian","year":"2011","journal-title":"J. Nucl. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1007\/s00259-024-06755-1","article-title":"A Deep Learning Model for Generating [18F]FDG PET Images from Early-Phase [18F]Florbetapir and [18F]Flutemetamol PET Images","volume":"51","author":"Sanaat","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Schmitt, J., Palleis, C., Sauerbeck, J., Unterrainer, M., Harris, S., Prix, C., Weidinger, E., Katzdobler, S., Wagemann, O., and Danek, A. (2021). Dual-Phase \u03b2-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.661284"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3233\/JAD-180232","article-title":"Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study","volume":"65","author":"Segovia","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Segovia, F., Gorriz, J.M., Ramirez, J., Martinez-Murcia, F.J., Castillo-Barnes, D., Sanchez-Vano, R., Sopena-Novales, P., and Gomez-Rio, M. (2018, January 12\u201314). Using Early Acquisitions of Amyloid-PET as a Surrogate of FDG-PET: A Machine Learning Based Approach. Proceedings of the 2018 International Workshop on Pattern Recognition in Neuroimaging, PRNI 2018, Singapore.","DOI":"10.1109\/PRNI.2018.8423959"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neucom.2020.06.081","article-title":"Multivariate Analysis of Dual-Point Amyloid PET Intended to Assist the Diagnosis of Alzheimer\u2019s Disease","volume":"417","author":"Segovia","year":"2020","journal-title":"Neurocomputing"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/978-3-030-31635-8_52","article-title":"Quantitative Analysis of Brain 18F-Fluordesoxyglucose and Early-Phase 18F-Florbetapir Positron Emission Tomography","volume":"Volume 76","author":"Seiffert","year":"2020","journal-title":"IFMBE Proceedings, Proceedings of the XV Mediterranean Conference on Medical and Biological Engineering and Computing\u2014MEDICON 2019"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Seiffert, A.P., G\u00f3mez-Grande, A., Villarejo-Galende, A., Gonz\u00e1lez-S\u00e1nchez, M., Bueno, H., G\u00f3mez, E.J., and S\u00e1nchez-Gonz\u00e1lez, P. (2021). High Correlation of Static First-Minute-Frame (Fmf) Pet Imaging After18f-Labeled Amyloid Tracer Injection with [18f]Fdg Pet Imaging. Sensors, 21.","DOI":"10.3390\/s21155182"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1097\/RLU.0000000000002768","article-title":"Early-Phase 18F-Florbetaben PET as an Alternative Modality for 18F-FDG PET","volume":"45","author":"Son","year":"2020","journal-title":"Clin. Nucl. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1007\/s00259-016-3353-1","article-title":"Early [18F]Florbetaben and [11C]PiB PET Images Are a Surrogate Biomarker of Neuronal Injury in Alzheimer\u2019s Disease","volume":"43","author":"Tiepolt","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3233\/JAD-180217","article-title":"Early after Administration [11 C]PiB PET Images Correlate with Cognitive Dysfunction Measured by the CERAD Test Battery","volume":"68","author":"Tiepolt","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13550-023-01041-x","article-title":"Head-to-Head Comparison of Relative Cerebral Blood Flow Derived from Dynamic [18F]Florbetapir and [18F]Flortaucipir PET in Subjects with Subjective Cognitive Decline","volume":"13","author":"Tuncel","year":"2023","journal-title":"EJNMMI Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"102750","DOI":"10.1016\/j.nicl.2021.102750","article-title":"Evaluation of the Early-Phase [18F]AV45 PET as an Optimal Surrogate of [18F]FDG PET in Ageing and Alzheimer\u2019s Clinical Syndrome","volume":"31","author":"Vanhoutte","year":"2021","journal-title":"Neuroimage Clin."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/s00259-022-06087-y","article-title":"Assessment of Perfusion Deficit with Early Phases of [18F]PI-2620 Tau-PET versus [18F]Flutemetamol-Amyloid-PET Recordings","volume":"50","author":"Beyer","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1007\/s00259-025-07175-5","article-title":"Correlation of Early-Phase \u03b2-Amyloid Positron-Emission-Tomography and Neuropsychological Testing in Patients with Alzheimer\u2019s Disease","volume":"52","author":"Eckenweber","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"102504","DOI":"10.1016\/j.nicl.2020.102504","article-title":"Tau PET and Relative Cerebral Blood Flow in Dementia with Lewy Bodies: A PET Study","volume":"28","author":"Wolters","year":"2020","journal-title":"Neuroimage Clin."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"102773","DOI":"10.1016\/j.nicl.2021.102773","article-title":"Dual-Phase 18F-Florbetaben PET Provides Cerebral Perfusion Proxy along with Beta-Amyloid Burden in Alzheimer\u2019s Disease","volume":"31","author":"Yoon","year":"2021","journal-title":"Neuroimage Clin."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2967\/jnumed.116.174615","article-title":"SNMMI Procedure Standard\/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0","volume":"57","author":"Minoshima","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2967\/jnumed.119.236240","article-title":"Evaluation of Dosimetry, Quantitative Methods, and Test\u2013Retest Variability of 18F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain","volume":"61","author":"Bullich","year":"2020","journal-title":"J. Nucl. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"100005","DOI":"10.1016\/j.eanmj.2025.100005","article-title":"Perspectives of the European Association of Nuclear Medicine (EANM) on Early Perfusion Imaging in the Context of Amyloid PET Imaging Protocols","volume":"1","author":"Morbelli","year":"2025","journal-title":"EANM J."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Gn\u00f6rich, J., Kusche-Palenga, J., Kling, A., Dehsarvi, A., Bronte, A., Frontzkowski, L., Zatcepin, A., Zaganjori, M., Sch\u00f6berl, F., and Roemer, S.N. (2025). Assessment and Staging of A\/T\/N with a Single Dynamic [18F]PI-2620 Recording. medRxiv.","DOI":"10.1101\/2025.01.14.25320240"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2967\/jnumed.120.244061","article-title":"One-Stop Shop: 18F-Flortaucipir PET Differentiates Amyloid-Positive and -Negative Forms of Neurodegenerative Diseases","volume":"62","author":"Hammes","year":"2021","journal-title":"J. Nucl. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/brain\/awad346","article-title":"Synthesizing Images of Tau Pathology from Cross-Modal Neuroimaging Using Deep Learning","volume":"147","author":"Lee","year":"2024","journal-title":"Brain"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e076790","DOI":"10.1002\/alz.076790","article-title":"Deep Learning Based Estimation of Synthetic Tau PET from Amyloid PET","volume":"19","author":"Naseri","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2967\/jnumed.120.254490","article-title":"Dynamic Amyloid PET: Relationships to 18F-Flortaucipir Tau PET Measures","volume":"63","author":"Raman","year":"2022","journal-title":"J. Nucl. Med."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Ruwanpathirana, G.P., Williams, R.C., Masters, C.L., Rowe, C.C., Johnston, L.A., and Davey, C.E. (2022). Mapping the Association between Tau-PET and A\u03b2-Amyloid-PET Using Deep Learning. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-18963-6"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e12415","DOI":"10.1002\/trc2.12415","article-title":"Tau as a Diagnostic Instrument in Clinical Trials to Predict Amyloid in Alzheimer\u2019s Disease","volume":"9","author":"Shcherbinin","year":"2023","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid Project: Standardizing Quantitative Amyloid Plaque Estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Alongi, P., Laudicella, R., Panasiti, F., Stefano, A., Comelli, A., Giaccone, P., Arnone, A., Minutoli, F., Quartuccio, N., and Cupidi, C. (2022). Radiomics Analysis of Brain [18 F]FDG PET\/CT to Predict Alzheimer\u2019s Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning Analysis. Diagnostics, 12.","DOI":"10.3390\/diagnostics12040933"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/RLU.0000000000005966","article-title":"A Robust Residual Three-Dimensional Convolutional Neural Networks Model for Prediction of Amyloid-\u03b2 Positivity by Using FDG-PET","volume":"50","author":"Ardakani","year":"2025","journal-title":"Clin. Nucl. Med."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Choi, D.H., Ahn, S.H., Chung, Y., Kim, J.S., Jeong, J.H., and Yoon, H.J. (2025). Machine Learning Model for Predicting Amyloid-\u03b2 Positivity and Cognitive Status Using Early-Phase 18F-Florbetaben PET and Clinical Features. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-00743-7"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s12149-022-01775-z","article-title":"Deep-Learning Prediction of Amyloid Deposition from Early-Phase Amyloid Positron Emission Tomography Imaging","volume":"36","author":"Komori","year":"2022","journal-title":"Ann. Nucl. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1177\/13872877251351275","article-title":"Machine Learning-Based Prediction of Amyloid Positivity Using Early-Phase F-18 Flutemetamol PET","volume":"106","author":"Park","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/mds.28373","article-title":"FDG-PET Patterns Predict Amyloid Deposition and Clinical Profile in Corticobasal Syndrome","volume":"36","author":"Parmera","year":"2021","journal-title":"Mov. Disord."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Rasi, R., and Guvenis, A. (2024). Predicting Amyloid Positivity from FDG-PET Images Using Radiomics: A Parsimonious Model. Comput. Methods Programs Biomed., 247.","DOI":"10.1016\/j.cmpb.2024.108098"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1002\/mp.15073","article-title":"Generation of Synthetic PET Images of Synaptic Density and Amyloid from 18F-FDG Images Using Deep Learning","volume":"48","author":"Wang","year":"2021","journal-title":"Med. Phys."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s11604-025-01789-3","article-title":"Evaluation of Amyloid PET Positivity Using Machine Learning on 18F-FDG PET Images","volume":"43","author":"Yamada","year":"2025","journal-title":"Jpn. J. Radiol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Zhou, B., Wang, R., Chen, M.-K., Mecca, A.P., O\u2019dell, R.S., Dyck, C.H.V., Carson, R.E., Duncan, J.S., and Liu, C. (2021). Synthesizing Multi-Tracer PET Images for Alzheimer\u2019s Disease Patients Using a 3D Unified Anatomy-Aware Cyclic Adversarial Network. arXiv.","DOI":"10.1007\/978-3-030-87231-1_4"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00259-021-05603-w","article-title":"EANM Procedure Guidelines for Brain PET Imaging Using [18F]FDG, Version 3","volume":"49","author":"Guedj","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_101","first-page":"128","article-title":"Biodistribution and Radiation Dosimetry of the Amyloid Imaging Agent 11C-PIB in Humans","volume":"48","author":"Scheinin","year":"2007","journal-title":"J. Nucl. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nucmedbio.2010.02.003","article-title":"Whole-Body Biodistribution and Brain PET Imaging with [18F]AV-45, a Novel Amyloid Imaging Agent\u2014A Pilot Study","volume":"37","author":"Lin","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11307-015-0924-7","article-title":"Human Radiation Dosimetry of [18F]AV-1451(T807) to Detect Tau Pathology","volume":"18","author":"Choi","year":"2016","journal-title":"Mol. Imaging Biol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Soret, M., Maisonobe, J.A., Desarnaud, S., Bergeret, S., Causse-Lemercier, V., Berenbaum, A., Rozenblum, L., Habert, M.O., and Kas, A. (2022). Ultra-Low-Dose in Brain 18F-FDG PET\/MRI in Clinical Settings. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-18029-7"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1148\/radiol.2018182573","article-title":"The Dawn of a New Era in Low-Dose PET Imaging","volume":"290","author":"Catana","year":"2018","journal-title":"Radiology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1148\/radiol.2018180940","article-title":"Ultra\u2013Low-Dose 18F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs","volume":"290","author":"Chen","year":"2018","journal-title":"Radiology"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/15\/12\/1271\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T05:13:51Z","timestamp":1764306831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/15\/12\/1271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":106,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["brainsci15121271"],"URL":"https:\/\/doi.org\/10.3390\/brainsci15121271","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]}}}